Although we have shown that SNPs in MMP2 and MMP9 are associated with increased risks of UTUC and metastasis, the effect of individual SNPs on cancer risks and outcomes is modest and not clinically applicable. The gene discussed is MMP2; the disease is renal pelvis/ureter urothelial carcinoma.